Zhixiong Lin

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong et al. · The Lancet · 2016 · 515 citations

Cisplatin Versus Fluorouracil, Medicine, Metronomic Therapy +6

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

Yunpeng Yang, Song Qu, Jingao Li et al. · The Lancet Oncology · 2021 · 429 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +8

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

Su-Mei Cao, Qi Yang, Ling Guo et al. · European Journal of Cancer · 2017 · 278 citations

Neoadjuvant Chemotherapy, Radiation Therapy, Medicine +9

Fluorine-18-Labeled Fluoromisonidazole Positron Emission and Computed Tomography-Guided Intensity-Modulated Radiotherapy for Head and Neck Cancer: A Feasibility Study

Nancy Y. Lee, James Mechalakos, Sadek A. Nehmeh et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 234 citations · Full text

Tomography-guided Intensity-modulated Radiotherapy, Neck Cancer, Medical Imaging +11

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial

Qi Yang, Su-Mei Cao, Ling Guo et al. · European Journal of Cancer · 2019 · 213 citations

Radiation Therapy, Medicine, Advanced Nasopharyngeal Carcinoma +9